Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2017-11-16 23:01:43 UTC |
---|
Update Date | 2022-03-07 03:18:13 UTC |
---|
HMDB ID | HMDB0240216 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Lafutidine |
---|
Description | Lafutidine, also known as protecadin, belongs to the class of organic compounds known as alkyl aryl ethers. These are organic compounds containing the alkyl aryl ether functional group with the generic formula R-O-R' , where R is an alkyl group and R' is an aryl group. In humans, lafutidine is involved in the lafutidine h2-antihistamine action pathway. Lafutidine is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on Lafutidine. |
---|
Structure | O=C(CS(=O)CC1=CC=CO1)NC\C=C/COC1=NC=CC(CN2CCCCC2)=C1 InChI=1S/C22H29N3O4S/c26-21(18-30(27)17-20-7-6-14-28-20)23-9-2-5-13-29-22-15-19(8-10-24-22)16-25-11-3-1-4-12-25/h2,5-8,10,14-15H,1,3-4,9,11-13,16-18H2,(H,23,26)/b5-2- |
---|
Synonyms | Value | Source |
---|
Protecadin | Kegg | (+)-2-[(2-Furanylmethyl)sulfinyl]-N-[(2Z)-4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]-2-butenyl]-acetamide | HMDB | (Z)-(+)-2-[(2-Furanylmethyl)sulfinyl]-N-[4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]-2-butenyl]-acetamide | HMDB | (+)-2-[(2-Furanylmethyl)sulfinyl]-N-[(2Z)-4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]-2-buten-1-yl]acetamide | HMDB | (+)-2-(Furfurylsulfinyl)-N-[(Z)-4-[[4-(piperidinomethyl)-2-pyridyl]oxy]-2-butenyl]acetamide | HMDB | (+)-Lafutidine | HMDB | FRG 8813 | HMDB | Laflutidine | HMDB | Lafukem | HMDB | Stogar | HMDB | Lafutidine | HMDB, MeSH | 2-(Furan-2-ylmethylsulphinyl)-N-[(Z)-4-[4-(piperidin-1-ylmethyl)pyridin-2-yl]oxybut-2-enyl]acetamide | Generator, HMDB | N-(4-(4-Piperidinylmethyl)pyridyl-2-oxy)-(Z)-butenyl-2-(furfurylsulfinyl)acetamide | MeSH, HMDB | N-(4-(4-Piperidinylmethyl)pyridyl-2-oxy)butenyl-2-(furfurylsulfinyl)acetamide | MeSH, HMDB |
|
---|
Chemical Formula | C22H29N3O4S |
---|
Average Molecular Weight | 431.55 |
---|
Monoisotopic Molecular Weight | 431.1878776 |
---|
IUPAC Name | 2-[(furan-2-yl)methanesulfinyl]-N-[(2Z)-4-({4-[(piperidin-1-yl)methyl]pyridin-2-yl}oxy)but-2-en-1-yl]acetamide |
---|
Traditional Name | lafutidine |
---|
CAS Registry Number | 118288-08-7 |
---|
SMILES | O=C(CS(=O)CC1=CC=CO1)NC\C=C/COC1=NC=CC(CN2CCCCC2)=C1 |
---|
InChI Identifier | InChI=1S/C22H29N3O4S/c26-21(18-30(27)17-20-7-6-14-28-20)23-9-2-5-13-29-22-15-19(8-10-24-22)16-25-11-3-1-4-12-25/h2,5-8,10,14-15H,1,3-4,9,11-13,16-18H2,(H,23,26)/b5-2- |
---|
InChI Key | KMZQAVXSMUKBPD-DJWKRKHSSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as alkyl aryl ethers. These are organic compounds containing the alkyl aryl ether functional group with the generic formula R-O-R' , where R is an alkyl group and R' is an aryl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Ethers |
---|
Direct Parent | Alkyl aryl ethers |
---|
Alternative Parents | |
---|
Substituents | - Alkyl aryl ether
- Aralkylamine
- Piperidine
- Pyridine
- Furan
- Heteroaromatic compound
- Amino acid or derivatives
- Carboxamide group
- Secondary carboxylic acid amide
- Sulfoxide
- Tertiary aliphatic amine
- Tertiary amine
- Carboxylic acid derivative
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Sulfinyl compound
- Organonitrogen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Organic oxide
- Organosulfur compound
- Amine
- Organopnictogen compound
- Carbonyl group
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Lafutidine,1TMS,isomer #1 | C[Si](C)(C)N(C/C=C\COC1=CC(CN2CCCCC2)=CC=N1)C(=O)CS(=O)CC1=CC=CO1 | 3540.1 | Semi standard non polar | 33892256 | Lafutidine,1TMS,isomer #1 | C[Si](C)(C)N(C/C=C\COC1=CC(CN2CCCCC2)=CC=N1)C(=O)CS(=O)CC1=CC=CO1 | 3343.2 | Standard non polar | 33892256 | Lafutidine,1TMS,isomer #1 | C[Si](C)(C)N(C/C=C\COC1=CC(CN2CCCCC2)=CC=N1)C(=O)CS(=O)CC1=CC=CO1 | 4388.7 | Standard polar | 33892256 | Lafutidine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C/C=C\COC1=CC(CN2CCCCC2)=CC=N1)C(=O)CS(=O)CC1=CC=CO1 | 3713.6 | Semi standard non polar | 33892256 | Lafutidine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C/C=C\COC1=CC(CN2CCCCC2)=CC=N1)C(=O)CS(=O)CC1=CC=CO1 | 3454.0 | Standard non polar | 33892256 | Lafutidine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C/C=C\COC1=CC(CN2CCCCC2)=CC=N1)C(=O)CS(=O)CC1=CC=CO1 | 4425.2 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Lafutidine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Lafutidine LC-ESI-qTof , Positive-QTOF | splash10-00di-0319500000-21e5d3163103c305767b | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Lafutidine , positive-QTOF | splash10-0uec-0629700000-2cad78fc15f4386b3645 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Lafutidine , positive-QTOF | splash10-00di-0319500000-21e5d3163103c305767b | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lafutidine 10V, Positive-QTOF | splash10-01qa-1676900000-3adc00bef17a159fb17e | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lafutidine 20V, Positive-QTOF | splash10-03fu-2971000000-7ee0ab341e67b0ccb95d | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lafutidine 40V, Positive-QTOF | splash10-01t9-4930000000-1265ca526856cae249ff | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lafutidine 10V, Negative-QTOF | splash10-001i-1930700000-aec8e386acbf098257aa | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lafutidine 20V, Negative-QTOF | splash10-0059-2920100000-149ac7afce52861c0b08 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lafutidine 40V, Negative-QTOF | splash10-0016-6900000000-695b1fd2b230388122f4 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lafutidine 10V, Positive-QTOF | splash10-001i-1015900000-d484d58eb169f3ec6743 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lafutidine 20V, Positive-QTOF | splash10-01q9-9453800000-eb9c012110cbed695f73 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lafutidine 40V, Positive-QTOF | splash10-001m-9400000000-c87dcefee5d75f368da0 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lafutidine 10V, Negative-QTOF | splash10-001i-1301900000-6c348a77d8546c865e4c | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lafutidine 20V, Negative-QTOF | splash10-01ox-5902100000-f69667109b92c6667827 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lafutidine 40V, Negative-QTOF | splash10-0h36-9711000000-19ce75902d45bf2db889 | 2021-09-24 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB12770 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 4445337 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Lafutidine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 5282136 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Shimatani T, Inoue M, Kuroiwa T, Xu J, Nakamura M, Tazuma S, Ikawa K, Morikawa N: Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine. Dig Dis Sci. 2006 Jan;51(1):114-20. [PubMed:16416222 ]
|
---|